Berlin, 1/02/2024.
Presentation of the perspectives of generative Artificial Intelligence in melanoma at the MPNEconsensus 2024 by the iToBoS partner Leibniz University Hannover.
Lennart Jütte is a PhD student from Leibniz University Hannover. At the Hannover Centre for Optical Technologies (HOT) he works in the Applied Optics and Photonics group led by Prof. Dr. Bernhard Roth. At the MPNEconsensus 2024 he presented on perspectives for generative AI in melanoma.
The MPNE consensus meeting in Berlin, part of a the iToBoS project, was not only about the integration of data and AI in melanoma care but also provided a unique platform for showcasing innovative applications of AI across various fields. One of the highlights was the exhibition on "Perspectives for Generative AI-assisted Art Therapy - Bridging Creativity and Technology: Innovating Art Therapy with AI." This presentation delved into how generative AI can revolutionize art therapy, offering new ways to foster creativity and therapeutic expression in patients. By integrating AI into art therapy, the exhibition explored potential advancements in personalized care, emphasizing the therapeutic benefits of combining technology with the creative process. Such innovative approaches underscore the meeting's broader theme of leveraging technology to enhance patient care and treatment outcomes.
For more details on the event, visit MPNEconsensus 2024’s webpage.
Figure 1 At MPNEconsensus 2024 researchers discussed perspectives for artificial intelligence
Figure 2 Lennart Jütte from Leibniz University Hannover presents new perspectives for Generative AI-assisted art therapy in Berlin
Figure 3 Exhibition at MPNEconsensus 2024.
Find out more at MPNE consensus 2024 on data, AI and data-dependent business models.